Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Holdings, Inc. Lantheus currently holds 11,563,425 shares of Perspective Therapeutics, Inc. (CATX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Holdings, Inc. Lantheus has been a net seller of CATX stock. They have purchased $0 and sold $111.6K worth of shares.
Holdings, Inc. Lantheus's most recent insider trade was on Sep 1, 2026, when they sold 35,769 shares at $3.12 per share.
Holdings, Inc. Lantheus serves as Executive at Perspective Therapeutics, Inc. (CATX). They have executed 1 insider transactions totaling $111.6K over their tenure at the company.
Holdings, Inc. Lantheus holds the position of Executive at Perspective Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Holdings, Inc. Lantheus has shown a selling trading pattern, with $0 in total purchases and $111.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Holdings, Inc. Lantheus was on Sep 1, 2026, when they sold $111.6K worth of CATX shares. This transaction involved 35,769 shares at $3.12 per share.
Holdings, Inc. Lantheus currently owns 11,563,425 shares of Perspective Therapeutics, Inc. (CATX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Holdings, Inc. Lantheus's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Holdings, Inc. Lantheus has 1 Form 4 filings on record as an insider at Perspective Therapeutics, Inc..
Set alerts for Holdings, Inc. Lantheus and 40,000+ other insiders.